GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
151 hedge funds and large institutions have $1.06B invested in GenMark Diagnostics, Inc in 2020 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 49 increasing their positions, 51 reducing their positions, and 38 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
9% more capital invested
Capital invested by funds: $974M → $1.06B (+$89M)
4% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 51
7% less funds holding
Funds holding: 163 → 151 (-12)
29% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 38
66% less call options, than puts
Call options by funds: $542K | Put options by funds: $1.61M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$68.4M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$17.8M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$10.5M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$7.15M |
| 5 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$5.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$16.5M |
| 2 |
Millennium Management
New York
|
-$11.9M |
| 3 |
AC
Armistice Capital
New York
|
-$11.2M |
| 4 |
CCM
Consonance Capital Management
New York
|
-$10.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$10.3M |
GNMK Hedge Fund Activity: Q4 2020 in Review
151 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q4 2020, worth a combined $1.06B — up 9.1% from $974M a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of GNMK and 27 opened new positions — a net loss of 11 holders — while 51 trimmed existing stakes and 49 added.
The largest buyer was Wasatch Advisors, adding an estimated $68.4M. The largest seller was Renaissance Technologies, cutting an estimated $16.5M.
- 151 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q4 2020, down from 163 in Q3 2020.
- Funds reported $1.06B of GenMark Diagnostics, Inc stock for Q4 2020, up 9.1% quarter-over-quarter.
- 27 funds opened new GenMark Diagnostics, Inc positions in Q4 2020 and 38 closed out, a net change of -11 holders.
- The largest GenMark Diagnostics, Inc buyer in Q4 2020 was Wasatch Advisors, an estimated $68.4M added.
- The largest GenMark Diagnostics, Inc seller in Q4 2020 was Renaissance Technologies, an estimated $16.5M sold.
Based on aggregated 13F filings for Q4 2020.